Medium materiality6/10
Kymera Therapeutics price target raised to $139 from $133 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises KYMR PT to $139; current price $105.48; price up 1.93% since signal.
- Barclays raises KYMR PT to $139; price $105.48; +1.93% since signal.
Key facts
- 01
Target: $139
- 02
Posted price: $105.48
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.